000			04875cam a2200613Ma 4500
001			sulb-eb0032556
003			BD-SySUS
005			20170713221335.0
006			m o d
007			cr |n||||||||a
008			110329s2013 gw fo 000 0 eng d
040			_aCDX _beng _epn _cCDX _dDG1 _dYDXCP _dNOC _dOCLCQ _dOCLCO _dOCLCF _dOCLCQ _dEBLCP _dBD-SySUS
020			_a9783527669417 _q(electronic bk.)
020			_a3527669418 _q(electronic bk.)
020			_a9781299448902 _q(MyiLibrary)
020			_a1299448909 _q(MyiLibrary)
020			_z9783527322831 _q(Cloth)
020			_z3527322833 _q(Cloth)
029	1		_aAU@ _b000051629414
029	1		_aCHBIS _b010026923
029	1		_aCHVBK _b30623761X
029	1		_aDEBBG _bBV043395820
029	1		_aGBVCP _b790207273
029	1		_aNZ1 _b15340137
029	1		_aNZ1 _b15905464
035			_a(OCoLC)842412695
037			_a476140 _bMIL
050		4	_aRM301.4
060		4	_aQV 38
082	0	4	_a615.1/9 _222
049			_aMAIN
245	0	0	_aModern biopharmaceuticals : _brecent success stories / _cedited by Jorg Knablein.
260			_aWeinheim : _bWiley-VCH Verlag GmbH, _c2013.
300			_a1 online resource (450 pages)
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
588	0		_aPrint version record.
505	0		_aRelated Titles; Title Page; Copyright; Dedication; Foreword by Andreas Busch; Foreword by Günter Stock; Preface; Quotes; List of Contributors; Part I: Modern Biopharmaceuticals: Research is the Best Medicine -- Sanitas Summum Bonus; Chapter 1: Twenty Thousand Years of Biotech -- From "Traditional" to "Modern Biotechnology"; 1.1 Biotechnology -- The Science Creating Life; 1.2 The Inauguration of Biotechnology; 1.3 From "Traditional" to "Modern Biotechnology"; 1.4 A Small Molecule from Bacteria -- A Huge Importance for Mankind; 1.5 Biopharmaceuticals -- The Mainstay of Modern Biotechnology
505	8		_a1.6 Transformation of the Pharma Industry Through Biotechnology1.7 Biopharmaceutical Production -- Uncorking Bottlenecks or Wasting Surplus Capacity?; 1.8 Conclusion and Outlook; References; Part II: Modern Biopharmaceutical Development Using Stem Cells, Tissues, and Whole Animals; Chapter 2: Induced Pluripotency as Substitute of Somatic Cell Nuclear Transfer? -- The Impact of Induced Pluripotent Stem Cells on Drug Discovery and Regenerative Biopharmaceuticals; 2.1 Introduction; 2.2 Derivation and Growth of hESC; 2.3 Signaling Pathways and Transcription Factors
505	8		_a2.4 Differentiation and Applications of hESC2.5 Patient-Specific Nuclear Transfer Stem Cells; 2.6 Patient-Specific Pluripotent Cells Through Direct Reprogramming of Adult Somatic Cells; 2.7 Concluding Remarks and Outlook; Acknowledgment; References; Chapter 3: Pluripotent Stem Cell-Derived Cardiomyocytes for Industrial and Clinical Applications; 3.1 Introduction; 3.2 Pluripotent Stem Cells; 3.3 High-Yield Differentiation of Pluripotent Stem Cells into Cardiomyocytes; 3.4 Purification of Pluripotent Stem Cell-Derived Cardiomyocytes; 3.5 Cardiomyocytes at an Industrial Scale
505	8		_a3.6 Utilization of Tissue Engineering Technologies to Advance Cellular Maturity3.7 Concluding Remarks; References; Chapter 4: Industrialization of Functional Mouse Genomics Technologies for Biopharmaceutical Drug Discovery and Development; 4.1 Introduction; 4.2 The Mouse Genetics Story; 4.3 Establishing Inducible Gene Targeting Tools; 4.4 RNAi -- Talking About a Revolution?; 4.5 Further Shortening the Generation Timeline for RNAi Mouse Models; 4.6 Adapting the Mouse Genetics Toolbox for New Applications; References; Part III: Innovative Development Tools for Modern Biopharmaceuticals
505	8		_aChapter 5: Standardized Solutions for Quantitative and Real-Time RT-PCR to Accelerate Biopharmaceutical Development5.1 Introduction; 5.2 Potential of Real-Time RT-PCR in Biopharmaceutical Development; 5.3 Accurate Gene Expression Analysis Depends on Standardized Preanalytical Steps; 5.4 Accuracy of Real-Time RT-PCR Depends on Efficient cDNA Synthesis; 5.5 Integration of Preanalytical Steps Streamlines Gene Expression Analysis; 5.6 Overview of Methods for Real-Time RT-PCR; 5.7 Developments in Real-Time PCR Instrumentation; 5.8 The Need for Better Standardization of Quantification Methods
650		0	_aBiopharmaceutics.
650		7	_aBiopharmaceutics. _2fast _0(OCoLC)fst00832650
655		4	_aElectronic books.
700	1		_aKnäblein, Jörg.
776	0	8	_iPrint version: _z9781299448902
856	4	0	_uhttp://onlinelibrary.wiley.com/book/10.1002/9783527669417 _zWiley Online Library [Free Download only for SUST IP]
938			_aEBL - Ebook Library _bEBLB _nEBL4044490
938			_aCoutts Information Services _bCOUT _n25218340
938			_aYBP Library Services _bYANK _n10350843
994			_a92 _bDG1
999			_c64208 _d64208